Efficacy and safety of hematopoietic and mesenchymal stem cells in multiple sclerosis: a meta-analysis
{{output}}
Objective: Currently available treatment options for multiple sclerosis (MS) have limited efficacy and/or safety concerns. Various mesenchymal stem cells and hematopoietic stem cells have been evaluated in recent clinical trials.... ...
